Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Three Ways to Eliminate Chaos in the Auto Casualty Claims Process
Discover practical strategies to overcome auto claims complexity and rising costs.
Ask The Pharmacist: CGRP Therapies for Migraine Management in Workers' Compensation
Migraines affect around one out of every six Americans in the adult population and can significantly impact workplace productivity and quality of life. For adjusters managing claims involving chronic or post-traumatic migraines, understanding emerging medication options can be the key to approving care that drives real recovery.
Migraine Medication Trends in Work Comp
Join Tom Kerr as he interviews Nikki Wilson, Senior Director of Clinical Pharmacy Services to dig into part one of our annual drug trends series. In this short video they’ll discuss standout trends from our most recent data focusing on migraine medications.
Calculating the Value of Evidence-Based PT
Placing the term “evidence-based” before a medical treatment would seem to give it instant credibility. But is this phrase simply a marketing phrase or is their true meaning behind it? In this Enlyte Envision podcast, Kim Radcliffe, DHA, MHA, PT, Senior Vice President of Product Management, helps us better understand evidence-based physical therapy and its true impact on recovery and claim costs.
Workers’ Compensation Institute (WCI) 2025 Conference
Enlyte is proud to return as an Elite Sponsor at the 2025 Workers' Compensation Institute (WCI) Conference in Orlando, Florida—th
Reclaim Control Over Specialty Costs
As specialty services become a major driver of rising expenses, effective management of medical costs requires a thoughtful, strategic approach. Based on data from internal calculations, these services now account for an astounding $6.4 billion annually in workers’ compensation medical spend, representing over 22% of total medical costs for many organizations.